Familial amyloidosis diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Fs}} | {{CMG}}; {{AE}}{{Fs}} | ||
== Overview == | == Overview == | ||
[[Biopsy|Tissue biopsy]] with [[Congo red|Congo red stain]] is the [[Gold standard (test)|gold standard test]] for the [[diagnosis]] of [[amyloidosis]]. [[Biopsy]] may be taken from an affected [[Organ (anatomy)|organ]] such as [[kidney]], or from [[subcutaneous fat]] or [[rectal]] [[Mucous membrane|mucosa]]. There are no established criteria for the [[diagnosis]] of familial amyloidosis. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
| Line 8: | Line 9: | ||
=== Study of choice === | === Study of choice === | ||
* Tissue biopsy with Congo red stain is the gold standard test for the diagnosis of | *[[Biopsy|Tissue biopsy]] with [[Congo red|Congo red stain]] is the [[Gold standard (test)|gold standard test]] for the [[diagnosis]] of [[amyloidosis]].<ref name="pmid12553428">{{cite journal |vauthors=Benson MD, Yazaki M, Magy N |title=Laboratory assessment of transthyretin amyloidosis |journal=Clin. Chem. Lab. Med. |volume=40 |issue=12 |pages=1262–5 |date=December 2002 |pmid=12553428 |doi=10.1515/CCLM.2002.218 |url=}}</ref> | ||
* Biopsy | *[[Biopsy]] may be taken from an affected [[Organ (anatomy)|organ]] such as [[kidney]], or from [[subcutaneous fat]] or [[rectal]] [[Mucous membrane|mucosa]]. | ||
* The rectal mucosa biopsy is | * The [[rectal]] [[mucosa]] [[biopsy]] is especially [[Sensitivity (tests)|sensitive]] for: | ||
** [[Transthyretin|Transthyretin (TTR)]] | **[[Transthyretin|Transthyretin (TTR)]] | ||
** [[Apolipoprotein AI]] | ** [[Apolipoprotein AI]] | ||
** Apolipoprotein AII | ** Apolipoprotein AII | ||
** [[Fibrinogen A alpha-chain associated amyloidosis|Fibrinogen Aa]] | ** [[Fibrinogen A alpha-chain associated amyloidosis|Fibrinogen Aa]] | ||
* Biopsy of the affected organ is recommended for patients with limited organ involvement.<ref name="pmid12479513">{{cite journal |vauthors=Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA |title=Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy |journal=Mayo Clin. Proc. |volume=77 |issue=12 |pages=1287–90 |date=December 2002 |pmid=12479513 |doi=10.4065/77.12.1287 |url=}}</ref> | *[[Biopsy]] of the affected [[Organ (anatomy)|organ]] is recommended for [[Patient|patients]] with limited [[Organ (anatomy)|organ]] involvement.<ref name="pmid12479513">{{cite journal |vauthors=Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA |title=Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy |journal=Mayo Clin. Proc. |volume=77 |issue=12 |pages=1287–90 |date=December 2002 |pmid=12479513 |doi=10.4065/77.12.1287 |url=}}</ref> | ||
* Biopsy from unaffected organs is more sensitive in patients with multi-organ involvement. | *[[Biopsy]] from unaffected [[Organ (anatomy)|organs]] is more [[Sensitivity (tests)|sensitive]] in [[Patient|patients]] with multi-organ involvement. | ||
===== Diagnostic | ===== Diagnostic Results ===== | ||
The following finding on | The following finding on [[Biopsy|tissue biopsy]] is confirmatory for familial amyloidosis:<ref name="pmid13657054">{{cite journal |vauthors=COHEN AS, CALKINS E |title=Electron microscopic observations on a fibrous component in amyloid of diverse origins |journal=Nature |volume=183 |issue=4669 |pages=1202–3 |date=April 1959 |pmid=13657054 |doi=10.1038/1831202a0 |url=}}</ref><ref name="pmid11552976">{{cite journal |vauthors=Kyle RA |title=Amyloidosis: a convoluted story |journal=Br. J. Haematol. |volume=114 |issue=3 |pages=529–38 |date=September 2001 |pmid=11552976 |doi=10.1046/j.1365-2141.2001.02999.x |url=}}</ref> | ||
* Apple green birefringence of the tissue sample under polarized light with Congo red stain. | * Apple green birefringence of the [[tissue]] sample under polarized light with [[Congo red|Congo red stain]]. | ||
* | * | ||
| Line 28: | Line 29: | ||
The various investigations must be performed in the following order: | The various investigations must be performed in the following order: | ||
* History | * History | ||
**Although all the familial amyloidosis types are autosomal dominant, different degree of temperance makes it difficult to diagnose the disease based on family history. | **Although all the familial amyloidosis types are [[autosomal dominant]], different degree of temperance makes it difficult to [[diagnose]] the [[disease]] based on [[family history]]. | ||
*Physical examination | *[[Physical examination]] | ||
*Biopsy | *[[Biopsy]] | ||
=== Name of Diagnostic Criteria === | === Name of Diagnostic Criteria === | ||
There are no established criteria for the diagnosis of familial amyloidosis. | There are no established criteria for the [[diagnosis]] of familial amyloidosis. | ||
==References== | ==References== | ||
Latest revision as of 19:47, 7 February 2020
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis diagnostic study of choice |
|
Risk calculators and risk factors for Familial amyloidosis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Tissue biopsy with Congo red stain is the gold standard test for the diagnosis of amyloidosis. Biopsy may be taken from an affected organ such as kidney, or from subcutaneous fat or rectal mucosa. There are no established criteria for the diagnosis of familial amyloidosis.
Diagnostic Study of Choice
Study of choice
- Tissue biopsy with Congo red stain is the gold standard test for the diagnosis of amyloidosis.[1]
- Biopsy may be taken from an affected organ such as kidney, or from subcutaneous fat or rectal mucosa.
- The rectal mucosa biopsy is especially sensitive for:
- Transthyretin (TTR)
- Apolipoprotein AI
- Apolipoprotein AII
- Fibrinogen Aa
- Biopsy of the affected organ is recommended for patients with limited organ involvement.[2]
- Biopsy from unaffected organs is more sensitive in patients with multi-organ involvement.
Diagnostic Results
The following finding on tissue biopsy is confirmatory for familial amyloidosis:[3][4]
- Apple green birefringence of the tissue sample under polarized light with Congo red stain.
Sequence of Diagnostic Studies
The various investigations must be performed in the following order:
- History
- Although all the familial amyloidosis types are autosomal dominant, different degree of temperance makes it difficult to diagnose the disease based on family history.
- Physical examination
- Biopsy
Name of Diagnostic Criteria
There are no established criteria for the diagnosis of familial amyloidosis.
References
- ↑ Benson MD, Yazaki M, Magy N (December 2002). "Laboratory assessment of transthyretin amyloidosis". Clin. Chem. Lab. Med. 40 (12): 1262–5. doi:10.1515/CCLM.2002.218. PMID 12553428.
- ↑ Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA (December 2002). "Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy". Mayo Clin. Proc. 77 (12): 1287–90. doi:10.4065/77.12.1287. PMID 12479513.
- ↑ COHEN AS, CALKINS E (April 1959). "Electron microscopic observations on a fibrous component in amyloid of diverse origins". Nature. 183 (4669): 1202–3. doi:10.1038/1831202a0. PMID 13657054.
- ↑ Kyle RA (September 2001). "Amyloidosis: a convoluted story". Br. J. Haematol. 114 (3): 529–38. doi:10.1046/j.1365-2141.2001.02999.x. PMID 11552976.